Iressa Case Control study in Japan
Study identifier:D791AL00002
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A nested case-control study to determine the relative risk of and risk factors for interstitial lung disease in a cohort of NSCLC patients treated with and without gefitinib
Medical condition
Non-small Cell Lung Cancer
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
6000
Study type
Observational
Age
N/A
Date
Study Start Date: 01 Nov 2003
Primary Completion Date: -
Study Completion Date: 01 Feb 2006
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Investigators
Principal Investigator
AstraZeneca Japan Medical Director
AstraZeneca
